Literature DB >> 34168184

Subtypes, resistance and virulence platforms in extended-drug resistant Acinetobacter baumannii Romanian isolates.

Irina Gheorghe1,2, Ilda Czobor Barbu1,2, Marius Surleac2,3, Ionela Sârbu2,4, Laura Ioana Popa1,2,5, Simona Paraschiv3, Yu Feng6, Veronica Lazăr1,2, Mariana Carmen Chifiriuc7,8,9, Dan Oţelea3, Zong Zhiyong6.   

Abstract

Acinetobacter baumannii has emerged worldwide as a dominant pathogen in a broad range of severe infections, raising an acute need for efficient antibacterials. This is the first report on the resistome and virulome of 33 extended drug-resistant and carbapenem-resistant A. baumannii (XDR CRAB) strains isolated from hospitalized and ambulatory patients in Bucharest, Romania. A total of 33 isolates were collected and analyzed using phenotypic antibiotic susceptibility and conjugation assays, PCR, whole-genome sequencing (WGS), pulsed-field gel electrophoresis (PFGE) and MultiLocus Sequence Typing (MLST). All isolates were extensively drug-resistant (XDR), being susceptible only to colistin. The carbapenem resistance was attributed by PCR mainly to blaOXA-24 and blaOXA-23 genes. PFGE followed by MLST analysis demonstrated the presence of nine pulsotypes and six sequence types. WGS of seven XDR CRAB isolates from healthcare-associated infections demonstrated the high diversity of resistance genes repertoire, as well as of mobile genetic elements, carrying ARGs for aminoglycosides, sulphonamides and macrolides. Our data will facilitate the understanding of resistance, virulence and transmission features of XDR AB isolates from Romanian patients and might be able to contribute to the implementation of appropriate infection control measures and to develop new molecules with innovative mechanisms of action, able to fight effectively against these bugs, for limiting the spread and decreasing the infection rate and mortality.

Entities:  

Year:  2021        PMID: 34168184     DOI: 10.1038/s41598-021-92590-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  48 in total

1.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report.

Authors:  Sofiane Bakour; Abiola Olumuyiwa Olaitan; Houria Ammari; Abdelaziz Touati; Souad Saoudi; Kenza Saoudi; Jean-Marc Rolain
Journal:  Microb Drug Resist       Date:  2015-01-14       Impact factor: 3.431

3.  Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria.

Authors:  Abir Ramoul; Lotfi Loucif; Sofiane Bakour; Sabrina Amiri; Mazouz Dekhil; Jean-Marc Rolain
Journal:  J Glob Antimicrob Resist       Date:  2016-06-11       Impact factor: 4.035

4.  Role of ISAba1 and ISAba125 in governing the expression of blaADC in clinically relevant Acinetobacter baumannii strains resistant to cephalosporins.

Authors:  B S Lopes; S G B Amyes
Journal:  J Med Microbiol       Date:  2012-04-12       Impact factor: 2.472

Review 5.  Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.

Authors:  Jason M Pogue; Tal Mann; Katie E Barber; Keith S Kaye
Journal:  Expert Rev Anti Infect Ther       Date:  2013-04       Impact factor: 5.091

Review 6.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 7.  Acinetobacter baumannii: evolution of a global pathogen.

Authors:  Luísa C S Antunes; Paolo Visca; Kevin J Towner
Journal:  Pathog Dis       Date:  2014-01-27       Impact factor: 3.166

8.  Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.

Authors:  Najla Mathlouthi; Allaaeddin Ali El Salabi; Mariem Ben Jomàa-Jemili; Sofiane Bakour; Charbel Al-Bayssari; Abdulaziz A Zorgani; Abdulmajeed Kraiema; Omar Elahmer; Liliane Okdah; Jean-Marc Rolain; Chedly Chouchani
Journal:  Int J Antimicrob Agents       Date:  2016-04-25       Impact factor: 5.283

Review 9.  Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance.

Authors:  Seyyed Naser Abdi; Reza Ghotaslou; Khudaverdi Ganbarov; Ahmad Mobed; Asghar Tanomand; Mehdi Yousefi; Mohammad Asgharzadeh; Hossein Samadi Kafil
Journal:  Infect Drug Resist       Date:  2020-02-12       Impact factor: 4.003

10.  Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii.

Authors:  Pauline D Mugnier; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more
  4 in total

1.  Five-Year Survey of Asymptomatic Colonization with Multidrug-Resistant Organisms in a Romanian Tertiary Care Hospital.

Authors:  Daniela Tălăpan; Alexandru Rafila
Journal:  Infect Drug Resist       Date:  2022-06-09       Impact factor: 4.177

2.  Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt.

Authors:  Samira M Hamed; Amira F A Hussein; Mohamed H Al-Agamy; Hesham H Radwan; Mai M Zafer
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

3.  Temporo-spatial variations in resistance determinants and clonality of Acinetobacter baumannii and Pseudomonas aeruginosa strains from Romanian hospitals and wastewaters.

Authors:  Irina Gheorghe-Barbu; Marius Surleac; Ilda Czobor Barbu; Laura Ioana Popa; Grațiela Grădișteanu Pîrcălăbioru; Marcela Popa; Luminița Măruțescu; Mihai Niță-Lazar; Alina Banciu; Cătălina Stoica; Ștefania Gheorghe; Irina Lucaciu; Oana Săndulescu; Simona Paraschiv; Daniela Talapan; Andrei Alexandru Muntean; Mădălina Preda; Mădălina-Maria Muntean; Cristiana Cerasella Dragomirescu; Mircea Ioan Popa; Dan Oțelea; Mariana Carmen Chifiriuc
Journal:  Antimicrob Resist Infect Control       Date:  2022-09-14       Impact factor: 6.454

4.  In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds.

Authors:  Tetyana Valeriyivna Denysko; Oleksandr Adamovych Nazarchuk; Oleksandr Gruzevskyi; Nataliia Ànatoliivna Bahniuk; Dmytro Valeriiovych Dmytriiev; Roman Mykolayovych Chornopyschuk; Vira Volodymyrivna Bebyk
Journal:  Front Microbiol       Date:  2022-10-04       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.